CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Oct. 26, 2024	Oct. 28, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 12,803	$ 11,585
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,955	8,967
Non-cash share-based compensation	862	924
Deferred taxes	(41)	(207)
Provision to value inventories at LIFO	118	466
Gain on sale of property, equipment and fixtures	0	(39)
Changes in assets and liabilities:
Merchandise inventories	(2,193)	(3,443)
Patronage dividend receivable	(5,564)	(4,849)
Accounts payable to Wakefern	516	4,216
Accounts payable and accrued expenses	1,005	3,954
Accrued wages and benefits	(666)	(1,420)
Income taxes receivable / payable	5,122	(2,602)
Other assets and liabilities	(742)	827
Net cash provided by operating activities	20,175	18,379
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(11,701)	(13,773)
Proceeds from the sale of assets	0	39
Investment in notes receivable from Wakefern	(2,202)	(2,139)
Investment in real estate partnership	(339)	(1,813)
Net cash used in investing activities	(14,242)	(17,686)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	21	0
Principal payments of long-term debt	(2,711)	(2,698)
Dividends	(3,324)	(3,350)
Treasury stock purchases	0	(782)
Net cash used in financing activities	(6,014)	(6,830)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(81)	(6,137)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	117,261	140,910
CASH AND CASH EQUIVALENTS, END OF PERIOD	117,180	134,773
SUPPLEMENTAL DISCLOSURES OF CASH  PAYMENTS MADE FOR:
Interest	990	1,064
Income taxes	769	8,135
NONCASH SUPPLEMENTAL DISCLOSURES:
Investment in Wakefern and increase in notes payable to Wakefern	0	38
Capital expenditures included in accounts payable and accrued expenses	9,290	5,086
Lease obligations obtained in exchange for right-of-use assets	$ 0	$ 908